GlassScriptPhysician profile
Zuhdi Eugene Abdo
NPI 1356845366
$12,191.89
in general payments reported to CMS, 2019-2025
11 companies · $4,458 in 2025
The $4,458 reported for 2025 was more than what a typical Adult Reconstructive Orthopaedic Surgery provider received nationally (typical 2025 total: $1,425).
See the full distribution for Adult Reconstructive Orthopaedic Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $1,427 · 2024: $6,307 · 2025: $4,458.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,564 · Travel and Lodging: $4,610 · Education: $1,018.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,564.05 |
| Travel and Lodging | $4,609.88 |
| Education | $1,017.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $8,201.48 | 2024-2025 | Persona, Avenir, Rosa |
| Stryker Corporation | $2,723.19 | 2023-2025 | Mako, Triathlon, Accolade |
| Depuy Synthes Sales INC. | $372.04 | 2024 | Tfn-Advance, Na, Velys |
| Davol INC. | $200.26 | 2024-2025 | Surgiphor |
| Medical Device Business Services, INC. | $178.82 | 2024 | Attune, Reclaim |
| Guard Medical INC. | $156.43 | 2025 | Npseal |
| Smith+Nephew, INC. | $148.39 | 2023 | Real Intelligence, Journey II |
| Ethicon US, LLC | $111.82 | 2025 | Vistaseal |
| Heraeus Medical, LLC. | $62.96 | 2024 | |
| Illuminoss Medical, INC. | $33.59 | 2023 | Photodynamic Bone Stabilization Procedure Pack |
| Think Surgical, INC. | $2.91 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Zuhdi Abdo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.